171 related articles for article (PubMed ID: 21139679)
1. Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.
Mott KR; Wechsler SL; Ghiasi H
Mol Vis; 2010 Oct; 16():2153-62. PubMed ID: 21139679
[TBL] [Abstract][Full Text] [Related]
2. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
3. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
4. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.
Ghiasi H; Osorio Y; Perng GC; Nesburn AB; Wechsler SL
J Virol; 2002 Sep; 76(18):9069-78. PubMed ID: 12186890
[TBL] [Abstract][Full Text] [Related]
6. Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.
Kintner RL; Allan RW; Brandt CR
Arch Virol; 1995; 140(2):231-44. PubMed ID: 7710352
[TBL] [Abstract][Full Text] [Related]
7. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.
Ghiasi H; Wechsler SL; Kaiwar R; Nesburn AB; Hofman FM
J Virol; 1995 Jan; 69(1):334-40. PubMed ID: 7983727
[TBL] [Abstract][Full Text] [Related]
8. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice.
Mott KR; Bresee CJ; Allen SJ; BenMohamed L; Wechsler SL; Ghiasi H
J Virol; 2009 Mar; 83(5):2246-54. PubMed ID: 19091870
[TBL] [Abstract][Full Text] [Related]
9. Herpes Simplex Virus 1 ICP22 Suppresses CD80 Expression by Murine Dendritic Cells.
Matundan H; Ghiasi H
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404803
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus-1 KOS-63 strain is virulent and causes titer-dependent corneal nerve damage and keratitis.
Moein HR; Sendra VG; Jamali A; Kheirkhah A; Harris DL; Hamrah P
Sci Rep; 2021 Feb; 11(1):4267. PubMed ID: 33608598
[TBL] [Abstract][Full Text] [Related]
11. Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity
Wang S; Ghiasi H
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511378
[TBL] [Abstract][Full Text] [Related]
12. Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice.
Allen SJ; Mott KR; Ghiasi H
Mol Vis; 2010 Jan; 16():98-104. PubMed ID: 20104254
[TBL] [Abstract][Full Text] [Related]
13. Small Noncoding RNA (sncRNA1) within the Latency-Associated Transcript Modulates Herpes Simplex Virus 1 Virulence and the Host Immune Response during Acute but Not Latent Infection.
Tormanen K; Matundan HH; Wang S; Jaggi U; Mott KR; Ghiasi H
J Virol; 2022 Apr; 96(7):e0005422. PubMed ID: 35254102
[TBL] [Abstract][Full Text] [Related]
14. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
Osorio Y; Ghiasi H
J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
[TBL] [Abstract][Full Text] [Related]
16. The role of T(H)1 and T(H)2 cytokines in HSV-1-induced corneal scarring.
Osorio Y; Sharifi BG; Perng G; Ghiasi NS; Ghiasi H
Ocul Immunol Inflamm; 2002 Jun; 10(2):105-16. PubMed ID: 12778346
[TBL] [Abstract][Full Text] [Related]
17. Loss of ICP22 in HSV-1 Elicits Immune Infiltration and Maintains Stromal Keratitis Despite Reduced Primary and Latent Virus Infectivity.
Matundan HH; Jaggi U; Wang S; Ghiasi H
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3398-3406. PubMed ID: 31387116
[TBL] [Abstract][Full Text] [Related]
18. The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity.
Mott KR; Chentoufi AA; Carpenter D; BenMohamed L; Wechsler SL; Ghiasi H
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2903-12. PubMed ID: 19168902
[TBL] [Abstract][Full Text] [Related]
19. Absence of CD28-CTLA4-PD-L1 Costimulatory Molecules Reduces Herpes Simplex Virus 1 Reactivation.
Matundan HH; Jaggi U; Yu J; Akbari O; Ghiasi H
mBio; 2021 Aug; 12(4):e0117621. PubMed ID: 34281386
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice.
Matundan HH; Mott KR; Allen SJ; Wang S; Bresee CJ; Ghiasi YN; Town T; Wechsler SL; Ghiasi H
J Virol; 2016 Oct; 90(20):9533-42. PubMed ID: 27512072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
